Detalhe da pesquisa
1.
Mesoscopic Heterogeneity in Pore Size of Supramolecular Networks.
Langmuir
; 34(25): 7503-7508, 2018 06 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29856633
2.
Evolution of heterogeneity accompanying sol-gel transitions in a supramolecular hydrogel.
Soft Matter
; 13(40): 7433-7440, 2017 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28967654
3.
Sol-gel transition accelerated by the co-assembly of two components in supramolecular hydrogels.
Phys Chem Chem Phys
; 17(40): 26724-30, 2015 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26394927
4.
Mesoscopic heterogeneity in a nanocellulose-containing cell storage medium.
J Mater Chem B
; 8(21): 4570-4574, 2020 06 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32412024
5.
NT-702 (parogrelil hydrochloride, NM-702), a novel and potent phosphodiesterase inhibitor, improves reduced walking distance and lowered hindlimb plantar surface temperature in a rat experimental intermittent claudication model.
Life Sci
; 81(12): 970-8, 2007 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17850826
6.
A retinoid X receptor antagonist, HX531, improves leptin resistance without increasing plasma leptin level in KK-Ay mice under normal dietary conditions.
Metabolism
; 54(5): 573-8, 2005 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15877285
7.
A novel peroxisome proliferator-activated receptor (PPAR)gamma agonist, NIP-222, reduces urinary albumin excretion in streptozotocin-diabetic mice independent of PPARgamma activation.
Metabolism
; 52(12): 1633-7, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14669169
8.
NT-702 (parogrelil hydrochloride, NM-702), a novel and potent phosphodiesterase 3 inhibitor, suppress the asthmatic response in guinea pigs, with both bronchodilating and anti-inflammatory effects.
Eur J Pharmacol
; 618(1-3): 63-9, 2009 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19616537
9.
Characterization of in vivo and in vitro electrophysiological and antiarrhythmic effects of a novel IKACh blocker, NIP-151: a comparison with an IKr-blocker dofetilide.
J Cardiovasc Pharmacol
; 51(2): 162-9, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18287884
10.
NIP-141, a multiple ion channel blocker, terminates aconitine-induced atrial fibrillation and prevents the rapid pacing-induced atrial effective refractory period shortening in dogs.
Europace
; 9(4): 246-51, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17350982
11.
Tertiapin, a selective IKACh blocker, terminates atrial fibrillation with selective atrial effective refractory period prolongation.
Pharmacol Res
; 54(2): 136-41, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16725344
12.
A novel nonpeptidyl human c-Mpl activator stimulates human megakaryopoiesis and thrombopoiesis.
Blood
; 107(11): 4300-7, 2006 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16484588
13.
Blockade by NIP-142, an antiarrhythmic agent, of carbachol-induced atrial action potential shortening and GIRK1/4 channel.
J Pharmacol Sci
; 101(4): 303-10, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16891768
14.
Xanthocillins as thrombopoietin mimetic small molecules.
Bioorg Med Chem
; 13(23): 6388-93, 2005 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16115772
15.
Atria selective prolongation by NIP-142, an antiarrhythmic agent, of refractory period and action potential duration in guinea pig myocardium.
J Pharmacol Sci
; 98(1): 33-40, 2005 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15879679
16.
Temporal gene expression changes during adipogenesis in human mesenchymal stem cells.
Biochem Biophys Res Commun
; 303(1): 306-12, 2003 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-12646203